We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000660:KRXSK hynix Inc. Analysis

Data as of 2026-09-09 - not real-time

₩1,793,000.00

Latest Price

9/10Risk

Risk Level: High

Executive Summary

SK hynix Inc. trades at KRW 1,793,000.00, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have lost 1.3%. Relative strength is 55.3 — neutral — and the MACD signal is bullish. The recent range runs from support at KRW 1,373,000.00 up to resistance at KRW 1,889,000.00.
On valuation the read is undervalued — earnings multiple of 3.8 versus a 33.3 sector average, below the peer group. Consensus targets land 78.3% above where the shares trade now. Revenue is growing at 256.8% on a 85.6% profit margin. The 0.08% dividend yield looks covered by current payout levels.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 125.1%, a beta of 2.07 and a maximum drawdown of 54.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 8 out of 10.

Top Market Events

Seeking Alpha22dSK hynix: AI Memory Dominance That Wall Street Is MispricingSK hynix Inc.Detailed price information for SK hynix Inc SKHY-Q from The Globe and Mail including charting and trades.Seeking Alpha19dSK hynix: The Buyback That Gets Worse As The Stock Gets BetterIn July, SK hynix Inc.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 1318130.00
  • MACD momentum is positive
  • 30-day volatility of 125.1%

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 3.8 versus sector average of 33.3
  • Trading above the 200-day average of 1318130.00
  • Analyst targets imply +78.3% versus the current price

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • P/E of 3.8 versus sector average of 33.3
  • Analyst targets imply +78.3% versus the current price
  • Profit margin of 85.6% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth256.80%
Profit Margin85.62%
P/E Ratio3.8
ROE354.06%
ROA56.85%
Debt/Equity72.08
Op. Cash Flow₩63054.9B
Free Cash Flow₩55768.1B
Industry P/E33.3

Technical Analysis

TrendNeutral
RSI55.3
Support₩1,373,000.00
Resistance₩1,889,000.00
MA 20₩1,648,450.00
MA 50₩1,803,020.00
MA 200₩1,318,130.00
MACDBullish
VolumeDecreasing
Fear & Greed Index93.36

Valuation

Fair Value₩2,756,872.30
Target Price₩3,197,603.80
Upside/Downside78.34%
GradeUndervalued
TypeBlend
Dividend Yield0.08%

Risk Assessment

Beta2.07
Volatility125.14%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.